TAICHUNG, TAIWAN (August 14, 2014) -- Bio-medical Carbon Technology Co., Ltd. (BCT), a leading global wound dressing developer and manufacturer, together with its U.S. distributor, Naka Won Int’l Corp. (Naka Won), on August 12, 2014, sponsored a symposium at TPC Summerlin, Las Vegas, Nevada to invite doctors and nurses to learn more about KoCarbonAg, the silver-coated activated carbon wound dressing and the flagship product of BCT. Dr. Ming-Wei Wu, D.O., Board Certified General and Wound Surgeon, presented “Challenges of BioBurden” and introduced KoCarbonAg. Dr. Wu applauded BCT’s efforts in developing advanced wound dressing and the efficacies of KoCarbonAg in treating and caring for wounds. KoCarbonAg has received 510(k) clearance from the U.S. Food and Drug Administration (U.S. FDA) in April, 2014. BCT is now partnered with Naka Won to introduce KoCarbonAg to the U.S. market.
About Bio-medical Carbon Technology
Bio-medical Carbon Technology, BCT, develops and manufactures ionic silver coated activated carbon fiber wound care dressings. Its products with proven effectiveness backed by the laboratory tests and clinical trials can treat a broad range of wound types, both acute and chronic wounds. It is proven that its products provide an easy, gentle, faster wound healing. BCT operates worldwide and is supported by its professionals and ongoing development and research. For more information, please visit www.bm-carbon.com